Ignite Creation Date:
2024-05-06 @ 4:06 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04871919
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-16
First Post:
2021-04-29
Brief Title:
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
Sponsor:
Galapagos NV
Organization:
Galapagos NV
Study Overview
Official Title:
A Prospective Non-interventional Study of the Effectiveness Safety and Health Related Outcomes in Patients With Moderate to Severe Active Rheumatoid Arthritis Receiving Filgotinib
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FILOSOPHY
Brief Summary:
An observational study to describe the effectiveness safety and patient-reported outcomes in patients with moderate to severe active rheumatoid arthritis RA receiving filgotinib in real-world setting
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 48323 | OTHER | HMA-EMA Catalogues | None |